Tirzepatide 5 mg
Dual GIP / GLP-1 Agonist
$35CAD · 5 mg vial
Purity ≥ 99%LyophilizedCOA included
A 5 mg presentation of the dual-agonist peptide targeting both GIP and GLP-1 receptors — a leading area of metabolic peptide research.
Choose pack
1
Research applications
- Dual-incretin receptor mechanisms
- Adipose tissue signalling
- Insulin-sensitivity models
For laboratory research use only. Not for human consumption.